BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Northwest Kinetics Participates In Clinical Trial For Venezuelan Equine Encephalitis Vaccine Candidate


3/22/2006 11:10:29 AM

TACOMA, Wash., March 22 /PRNewswire/ -- Northwest Kinetics Inc. in Tacoma, Wash. has entered into a pivotal phase I clinical trial with DVC LLC, a CSC company, for evaluation of the Venezuelan equine encephalitis (VEE) vaccine candidate V3526. VEE is a mosquito-transmitted viral disease that causes encephalitis in horses and humans. It is an important public health problem in Central and South America. The trial will evaluate the safety, tolerability and immunogenicity of the vaccine candidate in healthy volunteers between the ages of 18 and 40. Clinical testing is underway at Northwest Kinetics and will continue into 2006. This work is being conducted under contract for the Department of Defense Joint Vaccine Acquisition Program (JVAP).

(Logo: http://www.newscom.com/cgi-bin/prnh/20060214/NKLOGO )

About Northwest Kinetics

Northwest Kinetics' vision is to be the premier early phase clinical research partner for pharmaceutical and biotechnology companies. Located in a brand new, built-to-suit facility with 148 beds in Tacoma Washington, we offer single-study capacity, advanced technical capability, and a full range of services for both short- and long-term Phase 0, I and II clinical studies of investigational drugs, vaccines, and devices. The facility's state-of-the-art design amplifies the company's strength in conducting complex and procedure- intensive trials. Sponsors' monitors enjoy private rooms, communications and business equipment support, and convenient access to the Clinical Investigators, Project Managers and other study personnel. Founded in 1995, we are the industry leader in the western United States. For more information, please visit www.nwkinetics.com.

Photo: http://www.newscom.com/cgi-bin/prnh/20060214/NKLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comNorthwest Kinetics Inc.

CONTACT: Colleen Hoke, Director of Business Operations of NorthwestKinetics Inc., +1-253-593-5304



Read at BioSpace.com

   
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES